Clinical Trial Update: Treatment With Crizotinib Single Patient Expanded Access IND 134375

View source ↗

Summary

This document reports a single-patient expanded-access use of crizotinib for inflammatory myofibroblastic tumor. The entry is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Myofibroblastic Tumor

Drugs mentioned

• Crizotinib (crizotinib)

Snippet

Sponsor: Jean M. Tersak, M.D. | Conditions: Inflammatory Myofibroblastic Tumour | Status: NO_LONGER_AVAILABLE